Impact of vitamin D deficiency on clinical outcomes in non-traumatic subarachnoid hemorrhage: A single-center prospective cohort study

There is growing evidence that neuroinflammation and systemic inflammatory response following SAH have a major effect on patients' outcomes. We hypothesized that due to the immunomodulating and neuroprotective properties, Vitamin D deficiency may contribute to unfavorable outcome in SAH patients. Consecutive patients admitted with acute non-traumatic SAH were prospectively included. Within 24 h of admission, serum 25(OH)vitamin D levels were measured. During the first 21 days after SAH, inflammatory markers were closely monitored, the development of any infectious complication was noted, and the onset of cerebral vasospasm was evaluated using transcranial color-coded Doppler. New ischemic lesions on follow-up computed tomography imaging were also documented. Patients' outcomes were assessed according to the modified Rankin Scale (mRS) and the Barthel's Index on days 14, 30, and 90. Onehundred fifteen patients were included, of whom 61 were vitamin D deficient (VDD, serum vitamin D < 50 nmol/L) and 54 were vitamin D sufficient (VDS, serum vitamin D ≧ 50 nmol/L). The incidence of new ischemic lesions was significantly higher in the VDD group (VDD: 68.63% vs. VDS: 40.74%, p = 0.008). The VDD group also had higher peaks in inflammatory markers and a tendency of higher incidence of infections (VDD: 42.62% vs. VDS: 24.07%, p = 0.057). A poor outcome, as defined by the mRS, was significantly more frequent among VDD patients (on day 90: VDD, 61.02% vs. VDS, 35.19%, p = 0.011). Our findings raise the potential harmful effects of D hypovitaminosis among patients with SAH. Vitamin D deficiency may contribute to greater inflammatory response and increased risk of secondary ischemia, infections, and poor clinical outcomes. Further studies will show whether low vitamin D levels measured at admission are the consequence of SAH severity or whether pre-ictus hypovitaminosis also plays a role in determining the worse prognosis.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-02-04
DOI
https://doi.org/10.1038/s41598-026-38728-9
Primary Topic
Intracranial Aneurysms: Treatment and Complications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of vitamin D deficiency on clinical outcomes in non-traumatic subarachnoid hemorrhage: A single-center prospective cohort study

László Novák, Béla Fülesdi, Lili Simon, János Kappelmayer et al.
Scientific Reports
Intracranial Aneurysms: Treatment and Complications
article

Impact of vitamin D deficiency on clinical outcomes in non-traumatic subarachnoid hemorrhage: A single-center prospective cohort study

László Novák, Béla Fülesdi, Lili Simon, János Kappelmayer, Dorottya Szántó, Csilla Molnár
article en

Abstract

There is growing evidence that neuroinflammation and systemic inflammatory response following SAH have a major effect on patients' outcomes. We hypothesized that due to the immunomodulating and neuroprotective properties, Vitamin D deficiency may contribute to unfavorable outcome in SAH patients. Consecutive patients admitted with acute non-traumatic SAH were prospectively included. Within 24 h of admission, serum 25(OH)vitamin D levels were measured. During the first 21 days after SAH, inflammatory markers were closely monitored, the development of any infectious complication was noted, and the onset of cerebral vasospasm was evaluated using transcranial color-coded Doppler. New ischemic lesions on follow-up computed tomography imaging were also documented. Patients' outcomes were assessed according to the modified Rankin Scale (mRS) and the Barthel's Index on days 14, 30, and 90. Onehundred fifteen patients were included, of whom 61 were vitamin D deficient (VDD, serum vitamin D < 50 nmol/L) and 54 were vitamin D sufficient (VDS, serum vitamin D ≧ 50 nmol/L). The incidence of new ischemic lesions was significantly higher in the VDD group (VDD: 68.63% vs. VDS: 40.74%, p = 0.008). The VDD group also had higher peaks in inflammatory markers and a tendency of higher incidence of infections (VDD: 42.62% vs. VDS: 24.07%, p = 0.057). A poor outcome, as defined by the mRS, was significantly more frequent among VDD patients (on day 90: VDD, 61.02% vs. VDS, 35.19%, p = 0.011). Our findings raise the potential harmful effects of D hypovitaminosis among patients with SAH. Vitamin D deficiency may contribute to greater inflammatory response and increased risk of secondary ischemia, infections, and poor clinical outcomes. Further studies will show whether low vitamin D levels measured at admission are the consequence of SAH severity or whether pre-ictus hypovitaminosis also plays a role in determining the worse prognosis.

Scientific ReportsVol. 16(1)
University of Debrecen (HU)
No poverty
Openalex Percentile: Top 68%
Intracranial Aneurysms: Treatment and Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.